Funded Tech Companies
Kenai Therapeutics
Headquartered in Cambridge, Kenai Therapeutics raised its funding from The Column Group, Euclidean Capital and Alaska Permanent Fund.
Company Overview
Company Name
Kenai Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
One Broadway 14th Floor Kendall Square
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
We are advancing off-the-shelf dopamine neuron replacement therapies as a disease-modifying and potentially curative treatment for neurological disorders. Our proprietary platform leverages a novel approach to treating central nervous system disorders, such as Parkinson's disease, by replacing neurons lost due to neurodegeneration.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/29/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Manusos
Chief Financial Officer
Rajesh Mistry
Chief Medical Officer
Howard Federoff
VP - General Counsel
Martin Ostrowski
Company Investors
- The Column Group
- Euclidean Capital
- Alaska Permanent Fund
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs